{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:41:22Z","timestamp":1792424482198,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":90,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Shanghai Changning Yixin Public Welfare Service Center\uff0c Shanghai Xinxin Medical Technology Development Foundation","award":["HX2025257"],"award-info":[{"award-number":["HX2025257"]}]},{"name":"the Foundation of Science and Technology Department of Sichuan Province","award":["2026YFHZ0072"],"award-info":[{"award-number":["2026YFHZ0072"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16565-3","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T07:17:19Z","timestamp":1784618239000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A single-cell derived immune risk score predicts recurrence in NSCLC following neoadjuvant chemo-immunotherapy"],"prefix":"10.1186","volume":"26","author":[{"given":"Jun","family":"Ge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuesong","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"issue":"4","key":"16565_CR1","first-page":"242","volume":"3","author":"H Uramoto","year":"2014","unstructured":"Uramoto H, Tanaka F. Recurrence after surgery in patients with NSCLC. Transl Lung Cancer Res. 2014;3(4):242\u20139.","journal-title":"Transl Lung Cancer Res"},{"issue":"13","key":"16565_CR2","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1200\/JCO.2015.63.4543","volume":"34","author":"LW Martin","year":"2016","unstructured":"Martin LW, D\u2019Cunha J, Wang X, Herzan D, Gu L, Abraham N, et al. Detection of Occult Micrometastases in Patients With Clinical Stage I Non-Small-Cell Lung Cancer: A Prospective Analysis of Mature Results of CALGB 9761 (Alliance). J Clin Oncol. 2016;34(13):1484\u201391.","journal-title":"J Clin Oncol"},{"issue":"8","key":"16565_CR3","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1056\/NEJMoa2502931","volume":"393","author":"PM Forde","year":"2025","unstructured":"Forde PM, Spicer JD, Provencio M, Mitsudomi T, Awad MM, Wang C, et al. Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer. N Engl J Med. 2025;393(8):741\u201352.","journal-title":"N Engl J Med"},{"issue":"19","key":"16565_CR4","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1056\/NEJMoa2311926","volume":"390","author":"T Cascone","year":"2024","unstructured":"Cascone T, Awad MM, Spicer JD, He J, Lu S, Sepesi B, et al. Perioperative Nivolumab in Resectable Lung Cancer. N Engl J Med. 2024;390(19):1756\u201369.","journal-title":"N Engl J Med"},{"issue":"1","key":"16565_CR5","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41591-023-02660-6","volume":"30","author":"JS Deutsch","year":"2024","unstructured":"Deutsch JS, Cimino-Mathews A, Thompson E, Provencio M, Forde PM, Spicer J, et al. Association between pathologic response and survival after neoadjuvant therapy in lung cancer. Nat Med. 2024;30(1):218\u201328.","journal-title":"Nat Med"},{"issue":"11","key":"16565_CR6","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1016\/j.cell.2025.03.018","volume":"188","author":"Z Liu","year":"2025","unstructured":"Liu Z, Yang Z, Wu J, Zhang W, Sun Y, Zhang C, et al. A single-cell atlas reveals immune heterogeneity in anti-PD-1-treated non-small cell lung cancer. Cell. 2025;188(11):3081\u2013e9619.","journal-title":"Cell"},{"issue":"1","key":"16565_CR7","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/s41392-023-01522-4","volume":"8","author":"Q Sun","year":"2023","unstructured":"Sun Q, Hong Z, Zhang C, Wang L, Han Z, Ma D. Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends. Signal Transduct Target Ther. 2023;8(1):320.","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"16565_CR8","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.ccell.2023.03.009","volume":"41","author":"JA Pai","year":"2023","unstructured":"Pai JA, Hellmann MD, Sauter JL, Mattar M, Rizvi H, Woo HJ, et al. Lineage tracing reveals clonal progenitors and long-term persistence of tumor-specific T cells during immune checkpoint blockade. Cancer Cell. 2023;41(4):776\u201390. e7.","journal-title":"Cancer Cell"},{"key":"16565_CR9","doi-asserted-by":"crossref","unstructured":"Peng Q, Xu Y, Yao X. scRNA\u2009+\u2009TCR-seq revealed dual TCR T cells antitumor response in the TME of NSCLC. J Immunother Cancer. 2024;12(9):e009376.","DOI":"10.1136\/jitc-2024-009376"},{"issue":"5","key":"16565_CR10","doi-asserted-by":"publisher","first-page":"100842","DOI":"10.1016\/j.xgen.2025.100842","volume":"5","author":"O Shorer","year":"2025","unstructured":"Shorer O, Pinhasi A, Yizhak K. Single-cell meta-analysis of T cells reveals clonal dynamics of response to checkpoint immunotherapy. Cell Genom. 2025;5(5):100842.","journal-title":"Cell Genom"},{"issue":"21","key":"16565_CR11","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","volume":"10","author":"RL Camp","year":"2004","unstructured":"Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004;10(21):7252\u20139.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"16565_CR12","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s43018-021-00292-8","volume":"3","author":"B Liu","year":"2022","unstructured":"Liu B, Hu X, Feng K, Gao R, Xue Z, Zhang S, et al. Temporal single-cell tracing reveals clonal revival and expansion of precursor exhausted T cells during anti-PD-1 therapy in lung cancer. Nat Cancer. 2022;3(1):108\u201321.","journal-title":"Nat Cancer"},{"issue":"2","key":"16565_CR13","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41577-019-0223-7","volume":"20","author":"A Kallies","year":"2020","unstructured":"Kallies A, Zehn D, Utzschneider DT. Precursor exhausted T cells: key to successful immunotherapy? Nat Rev Immunol. 2020;20(2):128\u201336.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"16565_CR14","doi-asserted-by":"publisher","first-page":"106484","DOI":"10.1016\/j.isci.2023.106484","volume":"26","author":"C Zhang","year":"2023","unstructured":"Zhang C, Sheng Q, Zhang X, Xu K, Jin X, Zhou W, et al. Prioritizing exhausted T cell marker genes highlights immune subtypes in pan-cancer. iScience. 2023;26(4):106484.","journal-title":"iScience"},{"issue":"2","key":"16565_CR15","doi-asserted-by":"publisher","first-page":"e70609","DOI":"10.1002\/ctm2.70609","volume":"16","author":"T Zhu","year":"2026","unstructured":"Zhu T, Teng X, Jiao Q, Ren Y, Wang Y, Feng M. T-cell exhaustion from a multiomics perspective: Differentiation mechanisms and regulatory networks in the journey from progenitor-Exhausted T cells to terminally exhausted T cells. Clin Transl Med. 2026;16(2):e70609.","journal-title":"Clin Transl Med"},{"key":"16565_CR16","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3389\/fimmu.2015.00344","volume":"6","author":"RJ Napier","year":"2015","unstructured":"Napier RJ, Adams EJ, Gold MC, Lewinsohn DM. The Role of Mucosal Associated Invariant T Cells in Antimicrobial Immunity. Front Immunol. 2015;6:344.","journal-title":"Front Immunol"},{"key":"16565_CR17","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.3389\/fimmu.2018.01489","volume":"9","author":"C Mortier","year":"2018","unstructured":"Mortier C, Govindarajan S, Venken K, Elewaut D. It Takes Guts to Cause Joint Inflammation: Role of Innate-Like T Cells. Front Immunol. 2018;9:1489.","journal-title":"Front Immunol"},{"key":"16565_CR18","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3389\/fendo.2019.00471","volume":"10","author":"MG Kazanietz","year":"2019","unstructured":"Kazanietz MG, Durando M, Cooke M. CXCL13 and Its Receptor CXCR5 in Cancer: Inflammation, Immune Response, and Beyond. Front Endocrinol (Lausanne). 2019;10:471.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"16565_CR19","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1111\/cas.70105","volume":"116","author":"M Yoshimitsu","year":"2025","unstructured":"Yoshimitsu M, Nakamura M, Kano S, Magara T, Kato H, Sakai A, et al. CXCL13 and CCL21 Induce Tertiary Lymphoid Structures and Enhance the Efficacy of Immunotherapy for Melanoma. Cancer Sci. 2025;116(8):2075\u201385.","journal-title":"Cancer Sci"},{"key":"16565_CR20","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ejca.2021.03.054","volume":"151","author":"M Rouanne","year":"2021","unstructured":"Rouanne M, Arpaia N, Marabelle A. CXCL13 shapes tertiary lymphoid structures and promotes response to immunotherapy in bladder cancer. Eur J Cancer. 2021;151:245\u20138.","journal-title":"Eur J Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16565-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16565-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16565-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:03:24Z","timestamp":1792422204000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16565-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16565"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16565-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"assertion":[{"value":"14 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"N\/A. This study is a secondary bioinformatic analysis, no primary data from patients were collected in this study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1257"}}